Clinical Safety

Are Enzymes Programmable Molecular Machines?
Research & Development Are Enzymes Programmable Molecular Machines?

The long-held view of enzymes as nature's exquisitely specific but single-minded catalysts is undergoing a profound transformation, giving way to a new paradigm that reimagines them as versatile, programmable molecular machines. This significant shift, fueled by remarkable discoveries in natural

Targeting Pro-Tumor Neutrophils – Review
Research & Development Targeting Pro-Tumor Neutrophils – Review

The intricate landscape of the tumor microenvironment is increasingly recognized not as a simple collection of malignant cells, but as a complex ecosystem where cancer’s fate is dictated by a dynamic interplay with the body's own immune system. The targeting of specific immune cell subsets

Ultra-Processed Foods Raise Death Risk for Cancer Survivors
Research & Development Ultra-Processed Foods Raise Death Risk for Cancer Survivors

For the millions of individuals navigating life after a cancer diagnosis, the path toward long-term health is often paved with difficult questions about lifestyle choices, especially diet. A groundbreaking study now provides a compelling piece of that puzzle, revealing a significant and concerning

How Does a Common Fungus Make Cancer More Deadly?
Research & Development How Does a Common Fungus Make Cancer More Deadly?

The microscopic world teeming within the human body harbors countless secrets, with recent discoveries now implicating a common fungus not as a mere passenger but as a sinister co-conspirator in the spread of deadly skin cancer. This revelation challenges conventional understanding by suggesting

How Is Royal Openness Changing Public Health?
Research & Development How Is Royal Openness Changing Public Health?

The British monarchy, an institution historically defined by its stoic reserve, took an unprecedented step in 2024 when both King Charles and Catherine, the Princess of Wales, publicly disclosed their cancer diagnoses, shattering centuries of protocol that shrouded royal health in secrecy. This

Could This Mouse Make Antibody Drugs Safer?
Research & Development Could This Mouse Make Antibody Drugs Safer?

For decades, the path from a promising antibody discovery in the lab to a life-saving therapy for patients has been fraught with uncertainty. Many drugs that show incredible potential in early tests ultimately fail in human trials, costing billions and delaying medical progress. Today we're

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later